Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Accessory Structures of the Skin: Nails01:05

Accessory Structures of the Skin: Nails

Nails are one of the important accessory structures of the skin. They are hard, protective structures that cover the dorsal surface of the distal phalanges of fingers and toes. Nails are composed of specialized keratinized cells and serve various functions, including protection, sensation, and manual dexterity.
The main components of a nail include the following.
Nail Plate: The nail plate is the visible portion of the nail that extends beyond the fingertips or toes. It is a hard, translucent...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geometric Assessment and Tissue Damage Control in Anatomically, Ultrasonographically, and Fluoroscopically Guided Intracapsular DICMO Osteotomies Conducted on Cadaveric Specimens.

Reports (MDPI)·2026
Same author

Reporting and Utilization of Patient-Reported Outcomes Measures in the Evaluation of Foot Orthoses Treatment: A Systematic Review.

Journal of foot and ankle research·2026
Same author

Preliminary Reference Values for Plantar Fat Pad Thickness Beneath the Metatarsal Heads and Its Relationship with Body Mass Index.

Healthcare (Basel, Switzerland)·2025
Same author

Anatomical Validation of a Selective Anesthetic Block Test to Differentiate Morton's Neuroma from Mechanical Metatarsalgia.

Reports (MDPI)·2025
Same author

Continuous Radiofrequency for Morton's Neuroma: Is There Complete Ablation? A Preliminary Report.

Healthcare (Basel, Switzerland)·2025
Same author

Influence of skin hydration level on the occurrence of blisters on the foot during hiking.

International wound journal·2024

Related Experiment Videos

A new onychocryptosis classification and treatment plan.

Alfonso Martínez-Nova1, Raquel Sánchez-Rodríguez, David Alonso-Peña

  • 1Podiatry, Department of Nursing, University of Extremadura, Cáceres, Spain.

Journal of the American Podiatric Medical Association
|September 29, 2007
PubMed
Summary

Onychocryptosis, or ingrown toenails, can cause pain and limit function. This study introduces a new Stage IV classification for this common foot condition, offering tailored treatment plans for all stages.

Related Experiment Videos

Area of Science:

  • Podiatry
  • Dermatology
  • Surgical Pathology

Background:

  • Onychocryptosis, commonly known as ingrown toenails, is a frequent condition affecting the nail apparatus, specifically the toenail damaging the nail fold.
  • This condition primarily impacts the hallux (big toe), leading to pain, inflammation, and functional limitations, resulting in numerous clinical consultations.

Purpose of the Study:

  • To classify onychocryptosis into distinct stages based on clinical presentation.
  • To propose a novel Stage IV for onychocryptosis, previously unclassified in medical literature.
  • To outline stage-specific treatment plans for onychocryptosis, including general and specific indications.

Main Methods:

  • Clinical observation and classification of onychocryptosis cases.
  • Development of a new staging system (Stages I, IIa, IIb, III, and IV).
  • Correlation of clinical stages with tailored treatment strategies, emphasizing appropriate surgical technique selection.

Main Results:

  • Established a comprehensive classification system for onychocryptosis, including a new Stage IV.
  • Defined treatment plans applicable to each identified stage of the condition.
  • Highlighted the importance of selecting patient-specific surgical techniques for effective onychocryptosis management.

Conclusions:

  • The proposed staging system provides a structured approach to understanding and managing onychocryptosis.
  • Tailored treatment plans based on the new classification can optimize patient outcomes.
  • Individualized surgical approach selection is crucial for successful onychocryptosis treatment.